In this phase i sbir the breast cancer adenocarcinoma cell line, MCF-7 will be treated with escalating doses of rhtfam and the impact of rhtfam on mitochondrial activity and apoptotic potential will…

Ended Definitive Contract Awarded

Contract number
HHSN261201000097C
Awardee
Awarding agency
Obligated
$196,192

Award facts

Opportunity
  • N43C0702125 Solicitation number
Contract value 100% obligated
$196,192.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 41 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Charlottesville, VA, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute (NCI) awarded a $196,192 Firm Fixed Price SBIR Phase I contract to Gencia Corporation, a minority-owned limited liability company. The contract aims to analyze the impact of the compound rhtFam on the mitochondrial activity and apoptotic potential of the MCF-7 breast cancer cell line. The contract was set aside for small businesses. No additional subcontractors were mentioned.

Description

In this phase i sbir the breast cancer adenocarcinoma cell line, MCF-7 will be treated with escalating doses of rhtfam and the impact of rhtfam on mitochondrial activity and apoptotic potential will be analyzed.

Quick answers

Who was awarded contract HHSN261201000097C?

HHSN261201000097C was awarded to Gencia Corporation by National Cancer Institute (National Institutes of Health) on September 22, 2010.

How much is contract HHSN261201000097C worth?

The government has obligated $196,192 on HHSN261201000097C.

Was contract HHSN261201000097C competed?

The extent of competition for HHSN261201000097C was full and open competition after exclusion of sources. The government received 41 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award